Pinxten Pharma Consulting SRL
Pinxten Pharma Consulting reported total assets of 108,395 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026).
The score of Pinxten Pharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pinxten Pharma Consulting's annual accounts
| 2025 | |
|---|---|
| Net result | 40,866 € |
| Equity | 42,866 € |
| Cash | 47,610 € |
| EBITDA | 62,221 € |
| Total assets | 108,395 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
Pinxten Pharma Consulting's financial analysis
- Solvency39.5%sector median: 60.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pinxten Pharma Consulting
Pinxten Pharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1020.316.472
- VAT number
- BE1020316472
- Peppol
- Registered · 0208:1020316472 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Feb 2025
- Registered office
- 3990 Peer
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Computer consultancy and computer facilities management activities (NACE 62200)
Pinxten Pharma Consulting (SRL) has been based in Peer since 2025, active in: computer consultancy and computer facilities management activities. For 2025, it reports a net profit of 40,866 € and equity of 42,866 €; its revenue is not published. Its solvency stands at 39.5%, below the median of its sector (60.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pinxten Pharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- Geleyte Engineering Computer consultancy and computer facilities management activities Laarne · balance sheet 103,143 €
- Entel Consulting Computer consultancy and computer facilities management activities Hoeilaart · balance sheet 144,246 €
- Spatial Effects Computer consultancy and computer facilities management activities Merksplas · balance sheet 107,441 €
- Consulting4Healthcare Computer consultancy and computer facilities management activities Lier · balance sheet 107,307 €
- Wanderplan Computer consultancy and computer facilities management activities Ghent · balance sheet 88,627 €
- COMU Computer consultancy and computer facilities management activities Boortmeerbeek · balance sheet 113,094 €
- Panaspora Computer consultancy and computer facilities management activities Molenbeek-Saint-Jean · balance sheet 107,077 €
- SR Consultancy Computer consultancy and computer facilities management activities Genappe · balance sheet 112,193 €
Frequently asked questions about Pinxten Pharma Consulting
What is the revenue of Pinxten Pharma Consulting?
Pinxten Pharma Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pinxten Pharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE1020316472 for Pinxten Pharma Consulting, if the company is VAT-registered. Its company number (CBE) is 1020.316.472.
Where is the registered office of Pinxten Pharma Consulting?
According to the CBE register, the registered office of Pinxten Pharma Consulting is in 3990 Peer.
What is the equity of Pinxten Pharma Consulting?
At the close of the 2025 financial year, the equity of Pinxten Pharma Consulting amounts to 42,866 €, a solvency of 39.5% of total assets.
Who manages Pinxten Pharma Consulting?
The register lists 1 active mandates at Pinxten Pharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pinxten Pharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →